top of page
Dr. Pat Keegan on the BackTable Urology Podcast

Dr. Pat Keegan

Urologist

1 Podcast on BackTable

Dr. Pat Keegan is a urologist and Executive Medical Director of Clinical Development at CG Oncology in Nashville, Tennessee.

Learn from the experiences and expertise of Dr. Pat Keegan and other leading voices in your specialty on the BackTable app.

Career Diversification for Urologists Beyond the Clinic
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 311  •  23 Jun 2026

Career Diversification for Urologists Beyond the Clinic

What happens when urologists look beyond the clinic and take on leadership in the life sciences industry? In this episode of BackTable Urology, host Dr. Raj Pruthi talks with Dr. Kelly Parsons and Dr. Pat Keegan about their journeys from academic urology to executive roles in biotech and pharma. They discuss what motivated their transitions, how physician expertise adds value in industry, and the realities of life outside of traditional clinical practice.

More from Dr. Pat Keegan

About

Dr. Pat Keegan is a physician leader specializing in oncology drug development and clinical research, currently serving as Executive Medical Director of Clinical Development at CG Oncology. In this role, he leads the clinical development of innovative therapies for bladder cancer, working closely with investigators to advance clinical trials evaluating novel oncolytic immunotherapies for patients with non-muscle invasive bladder cancer. His work focuses on translating scientific discoveries into new treatment options while supporting collaborations between academic researchers, community physicians, and industry partners.

Dr. Keegan earned his medical degree and Master of Public Health from Vanderbilt University School of Medicine and has built a career spanning academic medicine, the pharmaceutical industry, and clinical development. Prior to joining CG Oncology, he held leadership positions overseeing oncology clinical research and therapeutic development, with expertise in genitourinary cancers and immuno-oncology. Through his leadership in clinical trials, scientific collaboration, and medical affairs, Dr. Keegan continues to contribute to the development of innovative bladder cancer therapies aimed at improving outcomes for patients worldwide.

Visit CG Oncology to learn more about Dr. Pat Keegan.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page